Entries by Nascent

Proven Cancer Cure Back in the Hands Of U.S. Inventor After 27 Years In Japan

SAN DIEGO – Mark Glassy, PhD, Chief Executive Officer and Co-founder of Nascent Biologics, Inc., (NBI), scientific researcher and inventor, announced today that he has recovered the license on his invention, “Pritumumab,” the first human antibody that has been used to treat cancer patients, after a 27 year absence in Japan. Dr. Glassy invented Pritumumab, […]